Ancora Heart
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4001 Burton Dr, Santa Clara, California,...Phone Number
(408) 727-1105Website
www.ancoraheart.comRevenue
$15.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Ancora Heart
Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company's proprietary AccuCinch® Ventricular Restoration System is the only completely transcatheter device designed to restore the structure and function of the enlarged left ventricle of the heart, thereby addressing the fundamental issue in the progression of heart failure in patients with reduced ejection fraction (HFrEF).Explore more
Ancora Heart Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ancora Heart your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ancora Heart, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ancora Heart launches new products
Congratulate Masked Content for being promoted to Masked Content at Ancora Heart
Click to see if Ancora Heart had a recent Job posting/layoffs
Earning: See what the market has to say on Ancora Heart recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ancora Heart has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Ancora Heart is spiking on competitors!
Check if Ancora Heart has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Ancora Heart
Find more new buyers
Compare Similar Companies to Ancora Heart
Compare insights from companies similar to Ancora Heart, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ancora Heart is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ancora Heart is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ancora Heart.
Ancora Heart financials insights
Gather financial insights about Ancora Heart, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Unspecified
$17.8M
2020
Debt
$350K
2021
Unspecified
$80M
Ancora Heart Tech Stack
A closer look at the technologies used by Ancora Heart
Most Recent Scoops
New Hire
Executive Move
New Hire
Executive Move
Ancora Heart has announced that Mark Miles has been named Chief Commercial Officer. Prevoiously, Miles served as the Chief Commercial Officer for Terumo Aortic.
Funding
Ancora Heart has received an SBA PPP loan for $350,000-1 million from Silicon Valley Bank.
Funding
, a medical device company, recently secured $23.46 million in funding.
Funding
Funding
Funding
Ancora Heart News & Media
Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
SANTA CLARA, Calif. & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- #accucinch--Ancora Heart, Inc., a medical device company developing a novel transcatheter device-based therapy to address heart failure (HF), and egnite, Inc., a leading digital health company in the field of cardiovascular care, today announced a strategic partnership to accelerate clinical trial enrollment for Ancora Heart’s CORCINCH-HF pivotal clinical trial, which is evaluating the safety and efficacy of the AccuCinch® VentricularAncora Heart’s AccuCinch System Demonstrates Significant Improvement in Quality of Life, Cardiac Structure and Function in Heart Failure Patients
BOSTON--(BUSINESS WIRE)-- #THT2023--New data from presented at THT 2023 showed positive outcomes for patients treated with Ancora Heart's AccuCinch® Ventricular Restoration System.Ancora Heart Announces Late-Breaking Clinical Science Presentation Among Key Activities at Technology and Heart Failure Therapeutics Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)-- #THT2023--Ancora Heart Announces Late Breaker Presentation at THT 2023Ancora Heart Appoints David J. Tucker as Chief Financial Officer
SANTA CLARA, Calif.--(BUSINESS WIRE)-- #accucinch--Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure (HF), today announced that David J. Tucker has joined the company as chief financial officer. He will direct the company’s financial strategies and operations as it continues to enroll patients in the CORCINCH-HF pivotal clinical trial, which is evaluating the AccuCinch® Ventricular Restoration System, the only completely transcatheter procedure to tre
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ancora Heart
Sign Up For FreeTo access detailed company insights
Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company's proprietary AccuCinch® Ventricular Restoration System is the only completely transcatheter device designed to restore the structure and function of the enlarged left ventricle of the heart, thereby addressing the f... Read More
